EUVIMEDEUVIMED entdecken
Crossref

Pancancer analysis of NDUFA4L2 with focused role in tumor progression and metastasis of colon adenocarcinoma

Runlong Zhou, Zhe Sun, Ruijie Zhou, Mengyi Wang, Qing Zhuo, Xiaotong Deng, Zhenrong Wang, Yao Xu

Medical Oncology · 2024

DOI: 10.1007/s12032-024-02531-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, 2024. Verfasst von Runlong Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biology and Medicine, College of Life Science and Health, Wuhan University of Science and Technology, Wuhan, 430081, Hubei, China. Hauptthemen laut MEDLINE: Adenocarcinoma, Colonic Neoplasms, Disease Progression, Electron Transport Complex I. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Wuhan East Lake High-tech Zone "JieBangGuaShuai" Project, Foundation of Hubei Province Supporting Enterprise Technology Innovation Development, Wuhan East Lake High-tech Zone “JieBangGuaShuai” Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colon adenocarcinoma (COAD) is a prevalent gastrointestinal malignant disease with a high mortality rate, and identification of novel prognostic biomarkers and therapeutic targets is urgently needed. Although NDUFA4L2 has high expressions in various tumors and affects tumor progression, its role in COAD remains unclear. The role of NDUFA4L2 in COAD was analyzed utilizing datasets available from public databases including The Cancer Genome Atlas, The Genotype-Tissue Expression (GTEx), Gene Expression Omnibus, Alabama Cancer Database (UALCAN), and The Human Protein Atlas databases. The prognostic value of NDUFA4L2 was determined using Kaplan-Meier analysis and Cox regression analysis. To investigate the possible mechanism underlying the role of NDUFA4L2 in COAD, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and gene set enrichment analysis (GSEA) were employed. The correlation between NDUFA4L2 expression and immune cell infiltration levels was examined through single-sample gene set enrichment analysis (ssGSEA). The NDUFA4L2 expression levels in COAD patients and cell lines were validated through immunohistochemistry, immunofluorescence, qRT-PCR, and Western blot. Wound healing assay was also performed to evaluate the effect of NDUFA4L2 on COAD metastasis. Furthermore, the NDUFA4L2 mediated competing endogenous RNA (ceRNA) regulatory network was predicted and constructed through a variety of databases. The comprehensive pan-cancer analysis showed that NDUFA4L2 possesses diagnostic and prognostic value in many cancers, especially in COAD. GO-KEGG and GSEA analyses indicated that NDUFA4L2 was associated with multiple biological functions including epithelial-mesenchymal transition and adaptation to hypoxia. The ssGSEA analysis showed that NDUFA4L2 expression was associated with immune infiltration. In vitro experiments confirmed upregulation of NDUFA4L2 in COAD tissues and cell lines, and NDUFA4L2 overexpression significantly promoted migration of COAD cells. In addition, the C9orf139 /miR-194-3p axis was speculated as the possible upstream regulators of NDUFA4L2 in COAD. This study demonstrated that NDUFA4L2 upregulation was correlated with tumor progression, relapsed prognosis and aggressive migration of COAD, suggesting that NDUFA4L2 can act as an effective prognostic biomarker and a promising therapeutic target for COAD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaColonic NeoplasmsDisease ProgressionElectron Transport Complex IFemaleHumansMaleMiddle AgedBiomarkers, TumorCell Line, TumorCell MovementEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticNeoplasm MetastasisPrognosis

Stichwörter der Autor:innen

Colon adenocarcinomaImmune infiltrationNDUFA4L2PrognosisTumor migration

Substanzen

Biomarkers, TumorNDUFA4L2 protein, humanElectron Transport Complex I

Autor:innen und Institutionen

  • Institute of Biology and Medicine, College of Life Science and Health, Wuhan University of Science and Technology, Wuhan, 430081, Hubei, China.
  • College of Biotechnology, Tianjin University of Science and Technology, Tianjin, China.
  • Institute of Biology and Medicine, College of Life Science and Health, Wuhan University of Science and Technology, Wuhan, 430081, Hubei, China. xuyao0307@wust.edu.cn.

Förderung

  • Wuhan East Lake High-tech Zone "JieBangGuaShuai" Project
  • Foundation of Hubei Province Supporting Enterprise Technology Innovation Development
  • Wuhan East Lake High-tech Zone “JieBangGuaShuai” Project

Zitieren

APA

Zhou, R., Sun, Z., Zhou, R., Wang, M., Zhuo, Q., Deng, X., Wang, Z., & Xu, Y. (2024). Pancancer analysis of NDUFA4L2 with focused role in tumor progression and metastasis of colon adenocarcinoma. Medical Oncology. https://doi.org/10.1007/s12032-024-02531-1

Vancouver

Zhou R, Sun Z, Zhou R, Wang M, Zhuo Q, Deng X, et al. Pancancer analysis of NDUFA4L2 with focused role in tumor progression and metastasis of colon adenocarcinoma. Medical Oncology. 2024. doi:10.1007/s12032-024-02531-1

BibTeX
@article{Zhou2024,
  author = {Zhou, Runlong and Sun, Zhe and Zhou, Ruijie and Wang, Mengyi and Zhuo, Qing and Deng, Xiaotong and Wang, Zhenrong and Xu, Yao},
  title = {Pancancer analysis of NDUFA4L2 with focused role in tumor progression and metastasis of colon adenocarcinoma},
  journal = {Medical Oncology},
  year = {2024},
  doi = {10.1007/s12032-024-02531-1}
}
Kostenlos starten →